Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Malignant Female Reproductive System Neoplasm Clinical Trial
Enhanced Recovery After Surgery Gynecology Oncology
Status: Enrolling
Updated: 9/12/2017
Prentice Women's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
Status: Enrolling, Phase II
Updated: 9/13/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Minnesota Oncology Hematology, PA
mi
from
Edina, MN
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology-Fort Worth 12th Ave.
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Waverly Hematology Oncology
mi
from
Cary, NC
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente-Fontana
mi
from
Fontana, CA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente West Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Bon Secours St. Francis Medical Center, Inc.
mi
from
Midlothian, VA
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Vince Lombardi Cancer Clinic - Oshkosh
mi
from
Oshkosh, WI
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology, Other Clinical Trial
Interventions for Reading Disabilities in NF1
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Patients With Previously Treated Cancer of the Colon or Rectum That Has Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bone Metastases Clinical Trial
Radiosurgical Hypophysectomy for Bone Metasteses Pain
Status: Enrolling
Updated: 12/31/1969
The Sidney Kimmel Comprehsensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Rapid Assessment of Esophageal Adenocarcinoma Risk Test
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
Status: Enrolling, Phase II
Updated: 3/5/2018
Stanford Cancer Center South Bay
mi
from
San Jose, CA
Click here to add this to my saved trials
Oncology Clinical Trial
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology - Baylor Charles A. Simmons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Baptist Health Medical Group Oncology, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Texas Oncology - San Antonio Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Jefferson Medical College of Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA
Status: Enrolling, Phase II
Updated: 12/31/1969
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Women's and Infant's Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Triple Negative Breast Cancer Clinical Trial
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Cancer Care
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Status: Enrolling, Phase III
Updated: 12/31/1969
UCLA School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Status: Enrolling, Phase III
Updated: 12/31/1969
Mcguire Va Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Status: Enrolling, Phase III
Updated: 12/31/1969
California Pacific Medical Center Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Nivolumab in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Status: Enrolling, Phase III
Updated: 12/31/1969
H. Lee Moffit Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Targeted Therapy With the IDH2-Inhibitor Enasidenib (AG221) for High-Risk IDH2-Mutant Myelodysplastic Syndrome
Status: Enrolling, Phase II
Updated: 12/31/1969
John Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Embryonic Ploidy Status in the Oncofertility Population
Status: Enrolling
Updated: 12/4/2017
Reproductive Medicine Associates of New Jersey
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Kidney Cancer Clinical Trial
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
HEAD AND NECK CANCER Clinical Trial
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
UC Health
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Status: Enrolling, Phase II
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Oncology Clinical Trial
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Status: Enrolling, Phase II
Updated: 12/31/1969
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Alphonsus Regional Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology Murfreesboro
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Menorah Medical Center
mi
from
Overland Park, KS
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Scri Florida Cancer Specialists North
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
SCRI Tennessee Oncology, PLLC Smyrna
mi
from
Smyrna, TN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling, Phase
Updated: 12/31/1969
Kettering Health Network
mi
from
Kettering, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Profiling Biospecimens From Cancer Patients to Screen for Molecular Alterations Related to Treatment Selection
Status: Enrolling, Phase
Updated: 12/31/1969
Kaiser Permanente Northwest
mi
from
Portland, OR
Click here to add this to my saved trials
Advanced Solid Tumor Clinical Trial
Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Avera Cancer Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
Status: Enrolling, Phase I
Updated: 4/18/2018
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
Status: Enrolling, Phase I
Updated: 4/18/2018
University of Southern California, Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Woodlands Medical Specialists
mi
from
Pensacola, FL
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Clinical Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
IU Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Breast Cancer Female Clinical Trial
PEMF and PEC Blocks in Mastectomy Reconstruction Patients
Status: Enrolling, Phase IV
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Oncology Clinical Trial
Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
Status: Enrolling, Phase II
Updated: 4/9/2018
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Oncology Hematology PC
mi
from
Albany, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
University of North Carolina- Lineberger Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology Oncology Associates of Central New York PC
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer Treatment Centers of America, Western Regional Medical Center
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Broome Oncology, LLC
mi
from
Johnson City, NY
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists and Research Institute
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
PRS-343 in HER2-Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California Los Angeles (UCLA)
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PRS-343 in HER2-Positive Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Georgetown University- Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Cooper Research Institute
mi
from
Camden, NJ
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Columbus Regional Research Institute
mi
from
Columbus, GA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Ohio Oncology Hematology, Inc.
mi
from
Columbus, OH
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Karmanos Cancer Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology - McAllen
mi
from
McAllen, TX
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Weill Cornell Medical College/New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois Cancer Specialists
mi
from
Niles, IL
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
GU Research Network, LLC
mi
from
Omaha, NE
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Pembrolizumab in Advanced BRCA-mutated Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Danbury Hospital
mi
from
Danbury, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Investigational Chemotherapy Service
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
Lac & Usc Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies
Status: Enrolling, Phase II
Updated: 12/31/1969
The University of Arizona Cancer Center - North Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
Status: Enrolling, Phase I
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Biobank for African American Prostate Cancer Research in Florida
Status: Enrolling, Phase
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials